AIM: To explore whether acute cellular DNA damage response is induced upon hepatitis B virus (HBV) infection and the effects of the HBV infection. METHODS: We incubated HL7702 hepatocytes with HBV-positive serum, mimicking a natural HBV infection process. We used immunoblotting to evaluate protein expression levels in HBV-infected cells or in non-infected cells; immunofluorescence to show ATR foci ands Chk1 phosphorylation foci formation; flow cytometry to analyze the cell cycle and apoptosis; ultraviolet (UV) radiation and ionizing radiation (IR)-treated cells to mimic DNA damage; and Trypan blue staining to count the viable cells. RESULTS: We found that HBV infection induced an increased steady state of ATR protein and increased phosphorylation of multiple downstream targets including Chk1, p53 and H2AX. In contrast to ATR and its target, the phosphorylated form of ATM at Ser-1981 and its downstream substrate Chk2 phosphorylation at Thr-68 did not visibly increase upon infection. However, the level of Mre11 and p21 were reduced beginning at 0.5 h after HBV-positive serum addition. Also, HBV infection led to transient cell cycle arrest in the S and the G2 phases without accompanying increased apoptosis. Research on cell survival changes upon radiation following HBV infection showed that survival of UV-treated host cells was greatly increased by HBV infection, owing to the reduced apoptosis. Meanwhile, survival of IR-treated host cells was reduced by HBV infection. CONCLUSION: HBV infection activates ATR DNA damage response to replication stress and abrogates the checkpoint signaling controlled by DNA damage response.
AIM: To explore whether acute cellular DNA damage response is induced upon hepatitis B virus (HBV) infection and the effects of the HBV infection. METHODS: We incubated HL7702 hepatocytes with HBV-positive serum, mimicking a natural HBV infection process. We used immunoblotting to evaluate protein expression levels in HBV-infected cells or in non-infected cells; immunofluorescence to show ATR foci ands Chk1 phosphorylation foci formation; flow cytometry to analyze the cell cycle and apoptosis; ultraviolet (UV) radiation and ionizing radiation (IR)-treated cells to mimic DNA damage; and Trypan blue staining to count the viable cells. RESULTS: We found that HBV infection induced an increased steady state of ATR protein and increased phosphorylation of multiple downstream targets including Chk1, p53 and H2AX. In contrast to ATR and its target, the phosphorylated form of ATM at Ser-1981 and its downstream substrate Chk2 phosphorylation at Thr-68 did not visibly increase upon infection. However, the level of Mre11 and p21 were reduced beginning at 0.5 h after HBV-positive serum addition. Also, HBV infection led to transient cell cycle arrest in the S and the G2 phases without accompanying increased apoptosis. Research on cell survival changes upon radiation following HBV infection showed that survival of UV-treated host cells was greatly increased by HBV infection, owing to the reduced apoptosis. Meanwhile, survival of IR-treated host cells was reduced by HBV infection. CONCLUSION:HBV infection activates ATR DNA damage response to replication stress and abrogates the checkpoint signaling controlled by DNA damage response.
Authors: Alvin T C Lee; Jianwei Ren; Ee-Tsin Wong; Kenneth H K Ban; Linda A Lee; Caroline G L Lee Journal: J Biol Chem Date: 2005-07-30 Impact factor: 5.157
Authors: Tom Stiff; Caroline Reis; Gemma K Alderton; Lisa Woodbine; Mark O'Driscoll; Penny A Jeggo Journal: EMBO J Date: 2004-12-16 Impact factor: 11.598
Authors: Alan Lau; Karra M Swinbank; Parvin S Ahmed; Debra L Taylor; Stephen P Jackson; Graeme C M Smith; Mark J O'Connor Journal: Nat Cell Biol Date: 2005-04-17 Impact factor: 28.824
Authors: Giuseppe Nunnari; Elias Argyris; Jianhua Fang; Ketti E Mehlman; Roger J Pomerantz; René Daniel Journal: Virology Date: 2005-05-10 Impact factor: 3.616
Authors: Caroline E Lilley; Christian T Carson; Alysson R Muotri; Fred H Gage; Matthew D Weitzman Journal: Proc Natl Acad Sci U S A Date: 2005-04-11 Impact factor: 11.205
Authors: Adriana Forero; Nicholas S Giacobbi; Kevin D McCormick; Ole V Gjoerup; Christopher J Bakkenist; James M Pipas; Saumendra N Sarkar Journal: J Immunol Date: 2014-05-05 Impact factor: 5.422
Authors: Barbora Lubyova; Eva Tikalova; Kristyna Krulova; Jan Hodek; Ales Zabransky; Ivan Hirsch; Jan Weber Journal: Viruses Date: 2021-12-05 Impact factor: 5.048